Search results
Lighthouse Investment Partners LLC Takes $421,000 Position in AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 6 days agoLighthouse Investment Partners LLC bought a new position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) in the fourth quarter, HoldingsChannel reports. The fund bought ...
Ethic Inc. Grows Stake in AstraZeneca PLC (NASDAQ:AZN)
ETF DAILY NEWS· 5 days agoEthic Inc. lifted its position in shares of AstraZeneca PLC (NASDAQ:AZN – Free Report) by 10.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The ...
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Market Watch· 5 days agoPublished: June 12, 2024 at 6:01 p.m. ETShareResizeBy Ben GlickmanAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes in children ...
Lung cancer: Why non-smokers don't respond to treatments
Medical News Today· 4 days agoResearchers report that people who have never smoked are less likely to respond to standard...
COVID-flu combo vaccine shows ‘positive’ results in phase 3 trials, Moderna says: A 'two-for' option
Fox News· 7 days agoA combination COVID-influenza vaccine is apparently one step closer to hitting the market. Moderna,...
This startup helps Americans get Ozempic and Adderall by using overseas freelancers
Quartz· 6 days agoA startup is working to help Americans navigate ongoing shortages of highly-coveted drugs like...
Why It's A New Day For COPD Patients — And Regeneron, Sanofi, Verona Stocks
Investor's Business Daily· 4 days agoRivals Face Off With Regeneron Stock The companies are far from alone in the burgeoning COPD...
Takeda circles a leukemia drug; J.P. Morgan moves into biotech investing
BioPharma Dive via Yahoo Finance· 3 days agoThe Japanese pharma paid $100 million to secure option rights to an Ascentage drug. Elsewhere, J.P....
Significant Benefit With Liver Transplantation in ACLF
Medscape· 5 days agoLiver transplantation improves survival in patients with acute-on-chronic liver failure (ACLF),...
FDA Expands Durvalumab Label to Endometrial Cancer
Medscape· 15 hours agoThe approval for mismatch repair deficient newly diagnosed advanced or recurrent endometrial cancer was based on improved progression-free survival vs placebo across 95 women.